MUCOFLUX

This brand name is authorized in Hong Kong SAR China, Singapore.

Active ingredients

The drug MUCOFLUX contains one active pharmaceutical ingredient (API):

1	Sobrerol UNII AI0NX02O35 - SOBREROL, TRANS-, (+/-)-
	Sobrerol is a mucolytic known due its emplyment in therapy for respiratory diseases. In preclinical studies sobrerol, administered daily at the oral dose of 400 mg/rat, markedly decreased the monocrotaline-induced alterations and regulate the development of pulmonary hypertension. Treatment with sobrerol was well tolerated and significantly reduced frontal headache and rhinorrhoea, efficacy being confirmed by rhinomanometry.
	Read more about Sobrerol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05CB07	Sobrerol	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	14592, 14593
SG	Health Sciences Authority	03031P, 03032P